Company: ABBV
Filing Date: 2025-03-10
Form Type: PRE 14A
Source: 0001558370-25-002603
Chunk: 107

Company: AbbVie Inc.
Filing Date: 2025-03-10
Form: PRE 14A
Chunk 107
---
 |

2025 Proxy Statement |A-1

Appendix B AbbVie Inc. Reconciliation of GAAP Reported to Non-GAAP Adjusted Information Year Ended December 31, 2024 (Unaudited) (In millions, except per share data) Non-GAAP Financial Results Financial results are presented on both a reported and a non-GAAP basis. Reported results were prepared in accordance with GAAP and include all revenues and expenses recognized during the period. Non-GAAP results adjust for certain non-cash items and for factors that are unusual or unpredictable, and exclude those costs, expenses, and other specified items. AbbVie’s management believes non-GAAP financial measures provide useful information to investors regarding AbbVie’s results of operations and assist management, analysts, and investors in evaluating the performance of the business. Non-GAAP financial measures should be considered in addition to, and not as a substitute for, measures of financial performance prepared in accordance with GAAP. 1.2024 Net Revenue Growth compared to 2023

| ​                                                                    | ​ | ​ | ​    |
| ​                                                                    | ​ | ​ |      |
| At actual currency rates (GAAP)                                      |   | ​ | 3.7% |
| Impact of foreign exchange                                           | ​ | ​ | 0.9% |
| Operational net revenue growth at constant currency rates (non-GAAP) |   | ​ | 4.6% |

2.Diluted Earnings Per Share since 2020

| ​                                                | ​ 
 ​ |     ​ 
  2024 | ​ |     ​ 
  2023 | ​ |     ​ 
  2022 | ​ |     ​ 
  2021 | ​ |     ​ 
  2020 |
|:-------------------------------------------------|:--|------:|:--|------:|:--|------:|:--|------:|:--|------:|
| As reported (GAAP)                               | $ |  2.39 | $ |  2.72 | $ |  6.63 | $ |  6.45 | $ |  2.72 |
| Adjusted for specified items:                    | ​ |     ​ | ​ |     ​ | ​ |     ​ | ​ |     ​ | ​ |     ​ |
| Intangible asset amortization                    | ​ |  3.63 | ​ |  3.76 | ​ |  3.61